[go: up one dir, main page]

DK1173434T3 - Thiazolidindionderivat og dets anvendelse som antidiabetisk middel - Google Patents

Thiazolidindionderivat og dets anvendelse som antidiabetisk middel

Info

Publication number
DK1173434T3
DK1173434T3 DK00920889T DK00920889T DK1173434T3 DK 1173434 T3 DK1173434 T3 DK 1173434T3 DK 00920889 T DK00920889 T DK 00920889T DK 00920889 T DK00920889 T DK 00920889T DK 1173434 T3 DK1173434 T3 DK 1173434T3
Authority
DK
Denmark
Prior art keywords
antidiabetic agent
thiazolidinedione derivative
thiazolidinedione
derivative
antidiabetic
Prior art date
Application number
DK00920889T
Other languages
English (en)
Inventor
Paul D J Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1173434(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909472.4A external-priority patent/GB9909472D0/en
Priority claimed from GBGB9912197.2A external-priority patent/GB9912197D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1173434T3 publication Critical patent/DK1173434T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK00920889T 1999-04-23 2000-04-19 Thiazolidindionderivat og dets anvendelse som antidiabetisk middel DK1173434T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909472.4A GB9909472D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912197.2A GB9912197D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001514 WO2000064892A2 (en) 1999-04-23 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
DK1173434T3 true DK1173434T3 (da) 2003-12-08

Family

ID=26315460

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02080320T DK1284268T3 (da) 1999-04-23 2000-04-19 Fremstilling af en polymorf form af et thiazolidindionderivat
DK00920889T DK1173434T3 (da) 1999-04-23 2000-04-19 Thiazolidindionderivat og dets anvendelse som antidiabetisk middel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02080320T DK1284268T3 (da) 1999-04-23 2000-04-19 Fremstilling af en polymorf form af et thiazolidindionderivat

Country Status (40)

Country Link
US (2) US6815457B1 (da)
EP (3) EP1284268B1 (da)
JP (1) JP2002543075A (da)
KR (1) KR100744359B1 (da)
CN (1) CN1208335C (da)
AP (1) AP1495A (da)
AR (2) AR023568A1 (da)
AT (2) ATE247653T1 (da)
AU (1) AU765498B2 (da)
BG (1) BG65427B1 (da)
BR (1) BR0009934A (da)
CA (1) CA2370258A1 (da)
CO (1) CO5170424A1 (da)
CY (1) CY1107238T1 (da)
CZ (1) CZ20013799A3 (da)
DE (2) DE60037602T2 (da)
DK (2) DK1284268T3 (da)
DZ (1) DZ3155A1 (da)
EA (1) EA004534B1 (da)
ES (2) ES2204557T3 (da)
HK (1) HK1045154B (da)
HR (1) HRP20010773B1 (da)
HU (1) HUP0200929A3 (da)
IL (1) IL146110A0 (da)
MA (1) MA26785A1 (da)
MX (1) MXPA01010820A (da)
MY (1) MY128007A (da)
NO (1) NO320589B1 (da)
NZ (1) NZ515163A (da)
OA (1) OA11871A (da)
PE (1) PE20010040A1 (da)
PL (1) PL351686A1 (da)
PT (2) PT1173434E (da)
RS (1) RS50114B (da)
SK (1) SK286423B6 (da)
TR (1) TR200103061T2 (da)
TW (1) TW591027B (da)
UA (1) UA67843C2 (da)
UY (1) UY26120A1 (da)
WO (1) WO2000064892A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
CO5170421A1 (es) 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto farmaceutico maleico
IL146110A0 (en) 1999-04-23 2002-07-25 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
MXPA03002580A (es) * 2000-09-26 2003-10-15 Cord Janet I Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
WO2003050116A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (en) * 2004-01-28 2006-10-11 Usv Limited A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288095B1 (en) 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
EP0306228B1 (en) 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
CN1083715C (zh) 1994-02-10 2002-05-01 史密丝克莱恩比彻姆有限公司 胰岛素敏化物治疗肾病的应用
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US20010044458A1 (en) * 1994-02-10 2001-11-22 Smithkline Beechamp P.L.C. Use of insulin sensitisers for treating renal diseases
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
NZ501163A (en) 1997-06-18 2002-02-01 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
GB9712866D0 (en) 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
AP1279A (en) 1997-06-18 2004-05-20 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin.
US20020028768A1 (en) * 1997-06-18 2002-03-07 Smithkline Beecham P.L.C. Treatment of diabetes with rosiglitazone and insulin
CN1274282A (zh) 1997-06-18 2000-11-22 史密丝克莱恩比彻姆有限公司 用噻唑烷二酮和α－葡糖苷酶抑制剂治疗糖尿病
US20020045649A1 (en) * 1997-07-18 2002-04-18 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
AP1607A (en) 1999-04-23 2006-05-03 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic.
IL146110A0 (en) 1999-04-23 2002-07-25 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
CO5170421A1 (es) 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto farmaceutico maleico
MXPA03002580A (es) 2000-09-26 2003-10-15 Cord Janet I Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.

Also Published As

Publication number Publication date
HRP20010773B1 (en) 2005-06-30
HK1045154A1 (en) 2002-11-15
RS50114B (sr) 2009-03-25
TR200103061T2 (tr) 2002-05-21
UA67843C2 (uk) 2004-07-15
NO20015149D0 (no) 2001-10-22
BR0009934A (pt) 2002-06-04
CO5170424A1 (es) 2002-06-27
MA26785A1 (fr) 2004-12-20
EA200101119A1 (ru) 2002-04-25
TW591027B (en) 2004-06-11
SK14912001A3 (sk) 2002-02-05
NO20015149L (no) 2001-12-17
US20040092555A1 (en) 2004-05-13
BG106119A (en) 2002-05-31
ATE382046T1 (de) 2008-01-15
AR023564A1 (es) 2002-09-04
JP2002543075A (ja) 2002-12-17
MXPA01010820A (es) 2002-06-04
DE60004658T2 (de) 2004-06-24
EP1284268A1 (en) 2003-02-19
HUP0200929A2 (en) 2002-08-28
ATE247653T1 (de) 2003-09-15
AR023568A1 (es) 2002-09-04
EP1284268B1 (en) 2007-12-26
KR20020028873A (ko) 2002-04-17
CY1107238T1 (el) 2012-11-21
WO2000064892A2 (en) 2000-11-02
DE60037602D1 (de) 2008-02-07
DE60037602T2 (de) 2009-01-08
PE20010040A1 (es) 2001-03-10
SK286423B6 (sk) 2008-09-05
ES2298327T3 (es) 2008-05-16
NO320589B1 (no) 2005-12-27
CN1208335C (zh) 2005-06-29
CN1355801A (zh) 2002-06-26
AU4130600A (en) 2000-11-10
PT1284268E (pt) 2008-03-10
MY128007A (en) 2007-01-31
WO2000064892A3 (en) 2001-01-25
HK1045154B (en) 2004-06-25
EP1903043A1 (en) 2008-03-26
CA2370258A1 (en) 2000-11-02
ES2204557T3 (es) 2004-05-01
YU75201A (sh) 2004-09-03
HUP0200929A3 (en) 2004-03-29
EP1173434B1 (en) 2003-08-20
IL146110A0 (en) 2002-07-25
DZ3155A1 (fr) 2000-11-02
HRP20010773A2 (en) 2002-10-31
AU765498B2 (en) 2003-09-18
HK1055293A1 (en) 2004-01-02
UY26120A1 (es) 2000-12-29
CZ20013799A3 (cs) 2002-04-17
DE60004658D1 (de) 2003-09-25
EP1173434A2 (en) 2002-01-23
NZ515163A (en) 2004-02-27
BG65427B1 (bg) 2008-07-31
PT1173434E (pt) 2003-12-31
US6815457B1 (en) 2004-11-09
DK1284268T3 (da) 2008-04-28
OA11871A (en) 2006-03-27
EA004534B1 (ru) 2004-06-24
PL351686A1 (en) 2003-06-02
AP1495A (en) 2005-11-30
KR100744359B1 (ko) 2007-07-30

Similar Documents

Publication Publication Date Title
DK1173434T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
NO20020383D0 (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
NO20020683L (no) Arylmetyl karbonylamino tiazolderivater og deres anvendelse som antitumormidler
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
DK1362027T3 (da) Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel
NO20021408L (no) Oksa- og tiadiazol-derivater anvendelige som antidiabetiske og antiovervektsmidler
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
ZA200108718B (en) Thiazolidinedione derivative and its use as antidiabetic.
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1173437T3 (da) Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
NO20030998L (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
NO20021612D0 (no) Karbonylstressreduserende middel
ATE330603T1 (de) Benzothiazolderivaten
DK1325000T3 (da) Thiazoldiendionderivat og dets anvendelse som antidiabetisk middel
DK1373249T3 (da) Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel
NO20015519D0 (no) Farmasöytisk sammensetning omfattende apokodein og/eller dets derivater
SI1173434T1 (en) Thiazolidinedione derivative and its use as antidiabetic
ES1046877Y (es) Sacacorchos articulado perfeccionado.
NO20005909D0 (no) Soppbasert middel samt fremstilling og anvendelse av dette
NO20014300L (no) Nytt protein og dets anvendelse